The global morphine market is estimated to grow at a CAGR of around 7% during the forecast period. Morphine is one of the medication which consist of various natural opiate components from plants and animals. It decreases the pain, both acute and chronic pain by impacting directly on central nervous system (CNS). Morphine drug such as capsules and tablets can be given by mouth and injection through the skin. The tablets and capsules effects after an hour and whereas it took 20 minutes through injection and effect is for 3-4 hours. The usage of opioid analgesics or opium has been increasing in the research & development (R&D) due to its various benefits such as reduces pain, inflammation, and an increase in appetite, reduces nausea and lastly controls epileptic seizures. These benefits are contributing to the growing demand for morphine in pain management. 

Morphine drugs eliminate the risk of stroke by reducing heart rate, maintain blood pressure and venous return is driving the market growth. Moreover, change in lifestyle and increasing surgical procedures is also creating demand for morphine drug prescription after surgery. Due to the rise in older populations suffering from diseases such as cancer, arthritis, myocardial infarction are among others increases the demand for morphine drugs which is prescribed as a painkiller.

Furthermore, rising in legal approvals of opioids or opium for developing medicines in different under-developed nations by the government is one of the opportunities for new and for existing players as well to expand their business globally. Moreover, intensive research & development (R&D) to develop novel medicines is also emerging as one of the opportunities in the global morphine market. However, strict rules & regulations and complex process framework hamper the global market growth. 

Segmentation

The global morphine market is segmented based on type and application. Based on type, the market is classified into capsules, oral tablets and injection. Based on the application, the market is classified into cough suppressants, diarrhea suppressants, anesthesia and others. The market has expected to witness high growth due to an increase in the consumption of oral tablets which are prescribed by the pharmacist as a painkiller to patients after surgery. The accurate dosage and high accessibility of oral tablets create ease of carrying hence, rises the demand compared to other types such as injections and capsules. 

Global Morphine Market Share by Type, 2019 (%)

Regional Outlook

Geographically, the global morphine market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominates the market due to the high demand for morphine for pain management and the availability of FDA approved morphine drugs. The high consumption of morphine in research & development for medical innovation is also driving the demand for morphine in the US. For instance, in November 2018, the FDA approved the R&D of morphine drug to develop new opioid painkiller. Whereas, in the Asia-Pacific region, the rising older population with arthritis and cancer, increases the demand for morphine medication as a painkiller. 

Global Morphine Market Growth, by Region 2019-2025

Competitive Landscape

The major companies providing morphine include Allergan PLC, Purdue Pharma LP, Mallinckrodt PLC, Mylan N.V., Sun Pharmaceutical Industries, Ltd., Macfarian Smith, Ltd., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries, Ltd. is among others. These players are making efforts to develop innovative drugs in order to compete in the market. Recently various morphine drug manufacturers have received US FDA approval for the new drug. For instance, in April 2020, Mallinckrodt Pharmaceuticals accepts the application of the FDA to develop the new drug to eliminate Hepatorenal Syndrome Type-1 (HRS-1). In September 2019, Purdue Pharma LP announced an agreement with FDA officials on opioid litigation settlement to trust and support new entrants in the market. In July 2018, Sun Pharmaceuticals Industries Ltd. Introduced Morphine sulfate extended to reduce the severe pain for long-term opioid treatments. 

The Report Covers

• Market value data analysis of 2020 and forecast to 2026.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global morphine market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.